Onconova Therapeutics Inc. (NASDAQ:ONTX)’s share price was up 7.4% on Thursday . The company traded as high as $4.12 and last traded at $4.07, with a volume of 1,057,410 shares. The stock had previously closed at $3.79.

Separately, Maxim Group set a $6.00 price target on Onconova Therapeutics and gave the stock a “buy” rating in a research note on Thursday, August 11th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $24.74.

The firm’s market capitalization is $10.00 million. The company has a 50 day moving average price of $4.15 and a 200 day moving average price of $4.77.

Onconova Therapeutics (NASDAQ:ONTX) last posted its quarterly earnings data on Monday, August 15th. The biopharmaceutical company reported ($1.96) EPS for the quarter. The business earned $2.25 million during the quarter. Equities research analysts predict that Onconova Therapeutics Inc. will post ($7.40) earnings per share for the current fiscal year.

Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.